Skip to main content

Table 2 Clinical characteristics of participants receiving care at Debre Markos and Felege Hiwot referral hospitals, Ethiopia, 2018–2019 (n = 186)

From: Effect of a self-care educational intervention to improve self-care adherence among patients with chronic heart failure: a clustered randomized controlled trial in Northwest Ethiopia

Variables Control group (n = 98) Treatment group (n = 88) p values
Frequency (%) Frequency (%)
Comorbidity
Yes 17 (17.3%) 32 (36.4%) 0.000
No 81 (82.7%) 56 (63.6%)
Current medication
Furosemide 87 (88.8%) 88 (100%)) 0.000
Spironolactone 76 (77.6%) 83 (94.3%)
ACE 42 (42.8%) 55 (62.5%)
Aspirin 44 (44.9%) 12 (13.6%)
Lipid lowering drugs 18 (18.3%) 12 (13.6%)
Beta blockers 51 (52%) 44 (50%)
History of hospitalization
Yes 67 (68.4%) 71 (80.7%) 0.06
No 31 (31.6%) 17 (19.3%)
Chronic heart failure stage
One 5 (5.7%) 0.000
Two 3 (3.1%) 14 (15.9%)
Three 19 (19.4%) 21 (23.9%)
Four 76 (77.6%) 48 (54.5%)
  1. ACE: Angiotensin converting enzyme inhibitors. In this study ACE inhibitors were captopril and enalapril
  2. Beta blockers were atenolol, metoprolol, and propranolol